Purchases and Sales Made in Q2 2025 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q2 2025. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
BUY
|
- |
10.7K+ 89.59% |
$10.8K - $13.9K
|
22.6K
$24.4K
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
9.2K+ 49.98% |
$9.29K - $12K
|
27.6K
$29.8K
|
|
Aug 14, 2025
Q2 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
BUY
|
- |
700+ 2.75% |
$707 - $910
|
26.2K
$28.3K
|
|
Aug 14, 2025
Q2 2025
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
469+ 642.47% |
$474 - $610
|
542
$585
|
|
Aug 13, 2025
Q2 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
300+ 0.61% |
$303 - $390
|
49.8K
$53.8K
|
|
Aug 13, 2025
Q2 2025
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
233+ 2330.0% |
$235 - $303
|
243
$262
|
|
Sep 04, 2025
Q2 2025
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
62+ 25.51% |
$62.6 - $80.6
|
305
$329
|
|
Aug 14, 2025
Q2 2025
|
Raymond James Financial Inc
St. Petersburg, FL |
BUY
|
- |
44New |
$44.4 - $57.2
|
44
$47.5
|
|
Aug 15, 2025
Q2 2025
|
Koesten, Hirschmann & Crabtree, Inc.
Overland Park, KS |
BUY
|
- |
1New |
$1.01 - $1.3
|
1
$1.08
|
|
Aug 12, 2025
Q2 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 11, 2025
Q2 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-71- 0.04% |
$71.7 - $92.3
|
194K
$210K
|
|
Aug 14, 2025
Q2 2025
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-653- 18.99% |
$660 - $849
|
2.79K
$3.01K
|
|
Aug 08, 2025
Q2 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-12.3K- 8.88% |
$12.5K - $16K
|
127K
$137K
|